UK markets closed
  • NIKKEI 225

    27,885.87
    +65.47 (+0.24%)
     
  • HANG SENG

    19,441.18
    -77.11 (-0.40%)
     
  • CRUDE OIL

    74.47
    -2.46 (-3.20%)
     
  • GOLD FUTURES

    1,783.20
    +1.90 (+0.11%)
     
  • DOW

    33,596.34
    -350.76 (-1.03%)
     
  • BTC-GBP

    14,009.65
    -53.20 (-0.38%)
     
  • CMC Crypto 200

    400.49
    -1.32 (-0.33%)
     
  • ^IXIC

    11,014.89
    -225.05 (-2.00%)
     
  • ^FTAS

    4,114.48
    -28.73 (-0.69%)
     

Global Biotechnology / Pharmaceutical Services Outsourcing Market to Reach $86 Billion by 2027

ReportLinker
ReportLinker

Abstract: What’s New for 2022? Global competitiveness and key competitor percentage market shares. Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Biotechnology / Pharmaceutical Services Outsourcing Industry" - https://www.reportlinker.com/p06361434/?utm_source=GNW
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global Biotechnology / Pharmaceutical Services Outsourcing Market to Reach $86 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Biotechnology / Pharmaceutical Services Outsourcing estimated at US$61.3 Billion in the year 2020, is projected to reach a revised size of US$86 Billion by 2027, growing at a CAGR of 5% over the analysis period 2020-2027. Consulting Services, one of the segments analyzed in the report, is projected to record a 4.9% CAGR and reach US$17.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Regulatory Affairs Services segment is readjusted to a revised 5.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $16.9 Billion, While China is Forecast to Grow at 8.3% CAGR

The Biotechnology / Pharmaceutical Services Outsourcing market in the U.S. is estimated at US$16.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$17.4 Billion by the year 2027 trailing a CAGR of 8.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.6% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$11.3 Billion by the year 2027.

Auditing & Assessment Segment to Record 4.9% CAGR

In the global Auditing & Assessment segment, USA, Canada, Japan, China and Europe will drive the 4.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$6.5 Billion in the year 2020 will reach a projected size of US$8.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.3% CAGR through the analysis period.

Select Competitors (Total 46 Featured) -
ABmas
Acuitas Therapeutics
Advanced Rx Management
AmerisourceBergen Corporation
Aquaconeer
Archbow Consulting
Aummune
Avara Pharmaceutical Services, Inc.
Avior Bio, Inc.
Bionostra


Read the full report: https://www.reportlinker.com/p06361434/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Biotechnology/Pharmaceutical Services Outsourcing - Global Key
Competitors Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Geographic Region -
Percentage Breakdown of Value Sales for USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Consulting Services by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Consulting Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Consulting Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Auditing & Assessment by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Auditing & Assessment by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Auditing & Assessment by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Regulatory Affairs Services by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Regulatory Affairs Services
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Regulatory Affairs
Services by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 13: World Recent Past, Current & Future Analysis for
Product Design & Development by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Product Design &
Development by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Product Design &
Development by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Product Testing & Validation by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Product Testing &
Validation by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Product Testing &
Validation by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 19: World Recent Past, Current & Future Analysis for
Other Services by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Other Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Other Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Biotechnology / Pharmaceutical Services
Outsourcing Market Analysis of Annual Sales in US$ Million for
Years 2012 through 2027

Table 23: World Recent Past, Current & Future Analysis for
Product Maintenance by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 24: World Historic Review for Product Maintenance by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 25: World 15-Year Perspective for Product Maintenance by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 26: World Recent Past, Current & Future Analysis for
Training & Education by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 27: World Historic Review for Training & Education by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 28: World 15-Year Perspective for Training & Education by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 29: World Recent Past, Current & Future Analysis for
Pharma by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 30: World Historic Review for Pharma by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 31: World 15-Year Perspective for Pharma by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 32: World Recent Past, Current & Future Analysis for
Biotech by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 33: World Historic Review for Biotech by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 34: World 15-Year Perspective for Biotech by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Biotechnology / Pharmaceutical Services Outsourcing Market
Presence - Strong/Active/Niche/Trivial - Key Competitors in
the United States for 2022 (E)
Table 35: USA Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 36: USA Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 37: USA 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 38: USA Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 39: USA Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 40: USA 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

CANADA
Table 41: Canada Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 42: Canada Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 43: Canada 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 44: Canada Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 45: Canada Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 46: Canada 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

JAPAN
Biotechnology / Pharmaceutical Services Outsourcing Market
Presence - Strong/Active/Niche/Trivial - Key Competitors in
Japan for 2022 (E)
Table 47: Japan Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 48: Japan Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 49: Japan 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 50: Japan Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 51: Japan Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 52: Japan 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

CHINA
Biotechnology / Pharmaceutical Services Outsourcing Market
Presence - Strong/Active/Niche/Trivial - Key Competitors in
China for 2022 (E)
Table 53: China Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 54: China Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 55: China 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 56: China Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 57: China Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 58: China 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

EUROPE
Biotechnology / Pharmaceutical Services Outsourcing Market
Presence - Strong/Active/Niche/Trivial - Key Competitors in
Europe for 2022 (E)
Table 59: Europe Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 60: Europe Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 61: Europe 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Geographic Region -
Percentage Breakdown of Value Sales for France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets for Years 2012,
2021 & 2027

Table 62: Europe Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 63: Europe Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 64: Europe 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 65: Europe Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 66: Europe Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 67: Europe 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

FRANCE
Biotechnology / Pharmaceutical Services Outsourcing Market
Presence - Strong/Active/Niche/Trivial - Key Competitors in
France for 2022 (E)
Table 68: France Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 69: France Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 70: France 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 71: France Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 72: France Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 73: France 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

GERMANY
Biotechnology / Pharmaceutical Services Outsourcing Market
Presence - Strong/Active/Niche/Trivial - Key Competitors in
Germany for 2022 (E)
Table 74: Germany Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 75: Germany Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 76: Germany 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 77: Germany Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 78: Germany Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 79: Germany 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

ITALY
Table 80: Italy Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 81: Italy Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 82: Italy 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 83: Italy Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 84: Italy Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 85: Italy 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

UNITED KINGDOM
Biotechnology / Pharmaceutical Services Outsourcing Market
Presence - Strong/Active/Niche/Trivial - Key Competitors in
the United Kingdom for 2022 (E)
Table 86: UK Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 87: UK Historic Review for Biotechnology / Pharmaceutical
Services Outsourcing by Service - Consulting Services,
Regulatory Affairs Services, Auditing & Assessment, Product
Design & Development, Product Testing & Validation, Product
Maintenance, Training & Education and Other Services Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 88: UK 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 89: UK Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 90: UK Historic Review for Biotechnology / Pharmaceutical
Services Outsourcing by End-Use - Pharma and Biotech Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 91: UK 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

SPAIN
Table 92: Spain Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 93: Spain Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 94: Spain 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 95: Spain Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 96: Spain Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 97: Spain 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage
Breakdown of Value Sales for Pharma and Biotech for the Years
2012, 2021 & 2027

RUSSIA
Table 98: Russia Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by Service -
Consulting Services, Regulatory Affairs Services, Auditing &
Assessment, Product Design & Development, Product Testing &
Validation, Product Maintenance, Training & Education and Other
Services - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 99: Russia Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Consulting
Services, Regulatory Affairs Services, Auditing & Assessment,
Product Design & Development, Product Testing & Validation,
Product Maintenance, Training & Education and Other Services
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 100: Russia 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by Service - Percentage
Breakdown of Value Sales for Consulting Services, Regulatory
Affairs Services, Auditing & Assessment, Product Design &
Development, Product Testing & Validation, Product Maintenance,
Training & Education and Other Services for the Years 2012,
2021 & 2027

Table 101: Russia Recent Past, Current & Future Analysis for
Biotechnology / Pharmaceutical Services Outsourcing by End-Use -
Pharma and Biotech - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 102: Russia Historic Review for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Pharma and
Biotech Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 103: Russia 15-Year Perspective for Biotechnology /
Pharmaceutical Services Outsourcing by End-Use - Percentage

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06361434/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001